UC Pancreatic Cancer Consortium
Events
UC Pancreatic Cancer Consortium Symposium
Pancreatic Cancer Screening in asymptomatic individuals with genetic susceptibility: state of the art and future directions
THURSDAY, JULY 22, 2021
8:30 AM – 12:30 PM PT
Keynote Speaker: Dr. Mimi Canto, Johns Hopkins University
UCPCC Seminar Series
August 3, 2021 8:00-9:00 AM
Speaker: Silke Paust (Scripps Research)
A Novel Immunocompetent PDX Model for Preclinical Testing of Pancreatic Cancer Therapies
Join the meeting using this link
August 19, 2021 8:00-9:00 AM
Speaker: Mark O’Hara (University of Pennsylvania)
CAR T cell combination strategies in pancreatic cancer
Join the meeting using this link
September 7, 2021 8:00-9:00 AM
Speaker: Matthew Vander Heiden (MIT)
How metabolism impacts pancreatic cancer progression
Join the meeting using this link
September 16, 2021 8:00-9:00 AM
Speaker: Elizabeth Jaffee (Johns Hopkins University)
Turning the Heat Up on Pancreatic Cancer: Lessons on Overcoming a “Cold” Immunologic Tumor Micro-environment
Join the meeting using this link
Who We Are
The mission of the UC Pancreatic Cancer Consortium (UCPCC) is to unite scientists and clinicians across the UC cancer centers committed to pancreatic cancer research and treatment in a highly collaborative environment that accelerates the progress and impact of our work.
Our vision is to improve the lives of persons diagnosed with pancreatic cancer by translating innovative research into improved clinical care.
UCPCC UC Leaders:
UC Davis Comprehensive Cancer Center – Richard Bold
UCI Health Chao Family Comprehensive Cancer Center – Murray Korc
UCLA Jonsson Comprehensive Cancer Center – Timothy Donahue
UC San Diego Moores Cancer Center – Andrew Lowy
UCSF Helen Diller Family Comprehensive Cancer Center – Margaret Tempero
Left to right; Dr’s Richard Bold, Andrew Lowy, Margaret Tempero, Tannishtha Reya, Julie Sutcliffe and Katie Couric at the Stand Up To Cancer 2019 Scientific Summit in Santa Monica, CA.
Biobanking:
David Dawson (UCLA)
Chang-il Hwang (UC Davis)
Alfredo Molinolo (UCSD)
Scott VandenBerg (UCSF)
Early Biology:
Guido Eibl (UCLA)
Michael Karin (UCSD)
Rushika Perera (UCSF)
Early Detection:
Gobind Anand (UCSD)
Mustafa Arain (UCSF)
Amie Blanco (UCSF)
Richard Bold (UC Davis)
Paige Bracci (UCSF)
Kenneth Chang (UCI)
Sun-Chuan Dai (UCSF)
Dena Goldberg (UCSF)
Stephen Kim (UCLA)
Kimberly Kirkwood (UCSF)
Venkataraman (Raman) Muthusamy (UCLA)
Jason Samarasena (UCI)
Imaging:
Johannes Czernin (UCLA)
Michael Hahn (UCSD)
Julie Sutcliffe (UC Davis)
Zhen (Jane) Wang (UCSF)
Inherited Susceptibility:
Julia Carnevale (UCSF)
Luis Carvajal-Carmona (UC Davis)
Wendy Conlon (UCLA)
Dena Goldberg (UCSF)
Lisa Madlensky (UCSD)
PDAC Clinical Trials:
Sepideh Gholami (UC Davis)
Edward Kim (UC Davis)
Andrew Ko (UCSF)
Aaron M. Miller (UCSD)
Hitendra (Hiten) Patel (UCSD)
Caius Radu (UCLA)
Zev Wainberg (UCLA)
PNET:
Martin Allen-Auerbach (UCLA)
Emily Bergsland (UCSF)
Johannes Czernin (UCLA)
Paul Fanta (UCSD)
Cameron Foster (UC Davis)
Randy (Joel) Hecht (UCLA)
Thomas Hope (UCSF)
Nancy Joseph (UCSF)
Edward Kim (UC Davis)
Karen E. Matsukuma (UC Davis)
Eric Nakakura (UCSF)
Julie Sutcliffe (UC Davis)
Robert Warren (UCSF)
Ronald Wolf (UCI)
Technology Assessment:
Eric Collisson (UCSF)
John McPherson (UC Davis)
UC Pancreatic Cancer Consortium Working Groups:
Funding Opportunities
Contact kurt.giles@ucsf.edu
Copyright 2021 © Regents of the University of California